Dr. Greenwald is an entrepreneur and biomedical engineer with over 15 years of experience in research and development in sports and orthopedic biomechanics. He founded Simbex (Lebanon, NH), a product development company, in 2000 and has been directly involved in product development for numerous biofeedback and data acquisition products for the medical and rehabilitation industries. He and Simbex have received multiple awards from the National Institutes of Health, National Science Foundation, and Department of Defense for product development through the Small Business Innovation Program (SBIR). He co-founded iWalk, Inc. (now BionX, Cambridge, MA) with Hugh Herr, PhD, to commercialize novel robotic prosthetic technologies, and was founding CEO from 2006-2009. Dr. Greenwald previously started and managed the US Division: Orthopedics, Sports, and Rehabilitation, for TÜV Product Service, a multinational firm specializing in product testing and regulatory certification of products for sale in the European Union. He recently served as a member of the National Advisory Child Health and Human Development Council of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, as a member of the Council of Councils, Office of the Director, National Institutes of Health and as President of the International Society for Skiing Safety. He is an Associate Professor (adjunct) at Thayer School of Engineering at Dartmouth College. Dr. Greenwald is currently directing five federally funded research and development projects.
Dr. Ann-Christine Duhaime, MD is the Director of the Pediatric Neurosurgery Department at Massachusetts General Hospital. She is a pediatric neurosurgeon who performed all types of pediatric neurosurgery with a particular emphasis on epilepsy surgery and trauma. As well as being a professor of neurosurgery at Harvard Medical School, she runs a brain trauma laboratory at MGH focused on understanding the immature brain and its response to injury and other conditions early in life, with the goal of helping infants and children. Tina is directly responsible for all clinical aspects of NEPDC, and together with Dr. Greenwald, coordinates all activities within NEPDC, including the MGH site, and helps facilitate involvement and continued productivity of collaborators in various other institutions and consortia. Specifically, she acts as a linkage and communication among pediatric-based clinicians at all sites, oversees regular web-based and phone conferences, and streamlines processes for submission of ideas via CIMIT that provides practical access for clinicians with limited time flexibility. As a practicing pediatric neurosurgeon, researcher (including bioengineering collaborations, large animal translational research, and pediatric clinical trials), and technology innovator, she serves as the main clinician link to the other members of the team.